tirzepatide 5.0 Zepbound 5 mg/0.5 mL injection (single-dose pen) Images GLP-1 medications have become one

If you experience severe symptoms like intense stomach pain, repeated vomiting, signs of dehydration, yellowing of the skin or trouble breathing, seek medical care right away

Ibuprofen 400 mg as needed

Below is an overview of how the two compare: Mechanism of Action: Retatrutide: Triple agonist (GLP-1, GIP, glucagon) Zepbound: Dual agonist (GLP-1, GIP) Developer: Retatrutide: Eli Lilly and Company (investigational) Zepbound: Eli Lilly and Company (approved) Regulatory Status: Retatrutide: Phase III clinical development Zepbound: FDA-approved for obesity, obstructive sleep apnea Weight Loss Efficacy: Retatrutide: Up to ~28.7% (68 weeks

The sense of control and progress in one domain (body weight) can spill over into motivation for other health improvements (smoking cessation)

doi:10.1159/000158636 [PubMed] [Karger] Koenig G, Seneff S